AI assistant
ASCENT RESOURCES PLC — Capital/Financing Update 2020
May 7, 2020
7500_nav_2020-05-07_fcb1c9c0-0c11-436f-850a-61a59fc7fe45.html
Capital/Financing Update
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
RNS Number : 1922M
Ascent Resources PLC
07 May 2020
Ascent Resources plc
("Ascent" or the "Company")
Fundraising Completion and Issue of Equity
7 May 2020
Ascent Resources Plc (LON: AST) the onshore Caribbean / Hispanic American and European oil and gas company, is pleased to announce, further to the previous announcement of 4 May, that it has now settled all remaining sums with the relevant investor and as a result has issued the final 2,250,000 Ordinary shares at a placing price of 5p per share. The placing previously announced on 14 February 2020 is now complete.
Application for admission to trading on AIM for the above has been made and admission is expected to take place on or around 15 May 2020.
In accordance with the provision of the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority, the Company confirms that, following the issue of the above shares, its issued ordinary share capital will comprise 59,109,652 ordinary shares. All of the ordinary shares have equal voting rights and none of the ordinary shares are held in Treasury. The total number of voting rights in the Company will therefore be 59,109,652. The above figure may be used by shareholders as the denominator for the calculations to determine if they are required to notify their interests in, or change to their interest in, the Company.
Enquiries:
| Ascent Resources plc Andrew Dennan |
Via Vigo Communications |
| WH Ireland, Nominated Adviser & Broker James Joyce / Chris Savidge |
0207 220 1666 |
| SP Angel, Joint Broker Richard Hail, Caroline Rowe |
0203 470 0470 |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
IOEVQLFBBELXBBZ